Certara, Inc. (HAM:700)

Market Cap	996.89M -50.3%
Revenue (ttm)	354.17M +11.5%
Net Income	9.27M
EPS	0.06
Shares Out	n/a
PE Ratio	107.53
Forward PE	14.10
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	160
Open	6.32
Previous Close	6.57
Day's Range	6.32 - 6.38
52-Week Range	6.38 - 11.63
Beta	n/a
RSI	24.21
Earnings Date	Feb 26, 2026

About Certara

Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and tr...

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Founded: 2008
• Employees: 1,546
• Stock Exchange: Hamburg Stock Exchange
• Ticker Symbol: 700

Financial Performance

In 2024, Certara's revenue was $385.15 million, an increase of 8.70% compared to the previous year's $354.34 million. Losses were -$12.05 million, -78.23% less than in 2023.

Financial numbers in USD